As ARID1A is an established metastasis gene in numerous tumor contexts [24,54–58], including endometrial cancer [59], we hypothesized that TP53 mutant primary tumors are not dependent on ARID1A function, and ARID1A mutations may promote metastasis in this genetic context. Here, TP53 is linked to endometrial cancer.